Correction to: MYL-1402O: A Bevacizumab Biosimilar
Crossref DOI link: https://doi.org/10.1007/s11523-022-00882-1
Published Online: 2022-04-18
Published Print: 2022-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, Arnold http://orcid.org/0000-0002-6519-7831
Text and Data Mining valid from 2022-04-18
Version of Record valid from 2022-04-18
Article History
First Online: 18 April 2022